Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Mobile Devices

June 13, 2018 — Medication management platform Medisafe released data showing that, on average, hypertensive patients ...

Home June 13, 2018
Home
News | Stroke

June 7, 2018 — Results from an international clinical trial show that combining clopidogrel and aspirin following a ...

Home June 07, 2018
Home
News | Heart Failure

May 30, 2018 — Data from the GENETIC-AF trial was presented in a “Late Breaking Clinical Trials” oral presentation at ...

Home May 30, 2018
Home
News | Stents Drug Eluting

May 29, 2018 – Investigators recently unveiled clinical data from the independently run Onyx 1-Month OCT Study showing ...

Home May 29, 2018
Home
A slide image from Reddy's presntation at Heart Rhythm 2018, showing thrombus formation on the face of a Watchman LAA Occluder device in an echo image. #HRS2018
Feature | Left Atrial Appendage (LAA) Occluders

May 18, 2018 — Left atrial appendage closure (LAAC) with the transcatheter Watchman device prevents thromboembolism from ...

Home May 18, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

May 18, 2018 — Nearly half of patients prescribed warfarin and just under one third of those using newer direct oral ...

Home May 18, 2018
Home
News | Atrial Fibrillation

 


May 18, 2018 — Three year results of a study found injection of botulinum toxin into epicardial fat pads in ...

Home May 18, 2018
Home
News | Atrial Fibrillation

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...

Home May 15, 2018
Home
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018
Feature | Cardiovascular Clinical Studies

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

Home May 14, 2018
Home
The blood of patients with familial chylomicronemia syndrome (FCS) can appear milky in color (lipemic) due to the buildup of fat in their body. Image courtesy of Akcea Therapeutics.
Feature | Cardiac Diagnostics | Steven D. Freedman, M.D., Ph.D.

 


In many cases, the diagnosis and management of patients with rare diseases can require the participation of ...

Home May 07, 2018
Home
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first ...

Home May 07, 2018
Home
Technology | Clinical Decision Support

April 30, 2018 — Point of Care Decision Support (PCDS) announced the release of a new version 2.0 of their ...

Home April 30, 2018
Home
News | Pharmaceuticals

April 6, 2018 — Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met its ...

Home April 06, 2018
Home
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18
Feature | ACC | Dave Fornell

There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American College ...

Home March 27, 2018
Home
News | Peripheral Artery Disease (PAD)

March 23, 2018 — Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence ...

Home March 23, 2018
Home
Subscribe Now